Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc.(TM) Signs Contract With Orthopedic Surgeon, Dr. Howard Kapp, in Support of $10 Million 2008 Revenue Goal
Recent Contracts Increase Digital Prescription Reauthorization Call Volume by 200%
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - April 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) announced today that the Company has signed a contract with Dr.
Howard Kapp in Naples, Florida, to implement the digiRX system and
digiReauth call center services. digiRX and digiReauth, which are both
proprietary, Microsoft-based applications developed by digiMedical, will
provide digital prescription handling for his office and will take over the
prescription reauthorization processing and refill management services. Dr.
Kapp is an Orthopedic Surgeon with Anchor Health Centers
(www.anchorhealthcenters.com). Dr. Kapp studied medicine at Case Western
Reserve University and completed his residency at Harvard University.
digiMedical Prescription Handling Software and Pharmacies
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
200% Prescription Reauthorization Call Volume Increase with Signing of
Recent Contracts
This contract follows digiMedical's recent announcements of other contracts
with Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, the
Medical Director of Vanish Vein and Laser Center and Dr. Wey of the
Neuroscience and Spine Associates in Naples, Florida, expanding the
Company's regional footprint in support of the Company's $10 million 2008
revenue goal.
digiMedical has seen an immediate increase in call volume for prescription
reauthorizations since adding these recent contracts. David Lee,
digiMedical CEO, stated, "We are very pleased with the quick results we
have seen from increasing our sales team in the Naples and Fort Meyers
markets. Not only have we recently added several new doctors, we have also
seen a significant increase in prescription reauthorizations with an over
200% call volume increase in our digiReauth center. Each new doctor can
add hundreds of patients to our network who in turn drive our prescription
sales and company revenue."
Bill Whitmore Joins Board of Advisors
Last week, digiMedical announced the appointment of Bill Whitmore to the
Company's Board of Advisors. Mr. Whitmore will assist the Company in
continuing to expand the sales team and sales strategies to support the
Company's 2008 $10 million revenue goal. Mr. Whitmore has nearly 10 years
of professional sales experience and is currently a Major Account Manager
for Logix Communications Enterprises, Inc., a $105 million dollar,
Houston-based telecommunications company.
Recent Analyst Report Coverage with Recommendation of $0.30 or Higher
Micros Report initiated research coverage of digiMedical Solutions and
issued a report reviewing the Company's historical operations and 2008
business plan. As described in the report, digiMedical has created a new
breed of pharmacy, integrating its own suite of proprietary software
handling prescriptions digitally and securely from the physician's office
into company owned brick and mortar pharmacies. According to the report,
prescription drug sales and utilization are growing rapidly and the market
is expected to grow 148% by 2016 to nearly $500 billion in sales.
Michael Willingham, Micros Report Director of Research, authored the report
which includes a Fair Value Target price for DGMS of $0.30. This valuation
is based on company characteristics that give it the potential to trade in
a range as high as $0.89 vs. the recent close of $0.07. In the report, Mr.
Willingham stated, "digiMedical's proprietary technology solution positions
the company to profit from both the traditional existing pharmacy market
space and the future of digital prescription fulfillment."
The report is available at http://www.digimedical.com/news/news.aspx under
"Featured Presentation." Interested parties may also access the report by
going to the www.MicrosReport.com homepage or by emailing
ir@digimedical.com and requesting a copy.
Corporate Overview Now Available on Yahoo! Finance
A Corporate Overview Report on the Company is now available on Yahoo!
Finance. The Report features digiMedical's proprietary, Microsoft-based
digital prescription handling technology, brick and mortar pharmacy
locations and recent Board of Directors expansion in preparation for a move
to the OTCBB. The Company has grown from a start-up in 2005 to forecasting
2008 revenues of $10 million. The report also highlights the first analyst
review on the company with a recommendation of $0.30 or higher.
To request a copy of the report, please go to
http://finance.yahoo.com/q?s=dgms.pk and click "Download Annual Report"
under the Company's stock chart.
Company Information and Updates
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to receive more information on the company, please
send an e-mail to ir@digimedical.com.
About Anchor Health Centers (www.anchorhealthcenters.com)
With locations throughout Southwest Florida, Anchor Health Center's
physicians are affiliated with two of the nation's top hospitals,
Massachusetts General Hospital and Brigham & Women's Hospital. Anchor's
physicians with experts in both specialty and primary care to ensure the
finest medical care available.
About digiMedical Solutions, Inc. ™
digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy
and medical technology company focused on developing next generation
digital medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'™ unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission for additional information and a
presentation of the risks and uncertainties that may affect the company's
business and results of operations.